Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: A prospective, double- blind, randomized trial

Medicine and Dentistry

• Respiratory Disease 100%
• Ribavirin 100%
• Human Respiratory Syncytial Virus 100%
• Lower Respiratory Tract 100%
• Child 100%
• Amaurosis 100%
• Patient 83%
• Inhalational Drug Administration 66%
• Diseases 50%
• Death 33%
• Hospital 33%
• Placebo 33%
• Intensive Care Unit 33%
• Artificial Respiration 16%
• Measurement 16%
• Intensive Care 16%
• Oxygen 16%
• Hypoxemia 16%
• Combination Therapy 16%
• Disease Course 16%
• Placebo-Controlled Study 16%
• Extubation 16%
• Absence 16%
• Inpatient 16%

Nursing and Health Professions

• Respiratory Tract Disease 100%
• Blindness 100%
• Ribavirin 100%
• Inhalational Drug Administration 66%
• Diseases 50%
• Ventilator 33%
• Death 33%
• Placebo 33%
• Clinical Outcome 16%
• Hypoxemia 16%
• Pediatric Intensive Care Unit 16%
• Measurement 16%
• Intensive Care Unit 16%
• Artificial Respiration 16%
• Combination Therapy 16%
• Oxygen 16%
• Outpatient Department 16%
• Extubation 16%
• Teaching Hospital 16%
• Placebo-Controlled Study 16%
• Dependent Variable 16%
• Time 16%
• Absence 16%
• Disease Course 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Respiratory Tract Disease 100%
• Ribavirin 100%
• Blindness 100%
• Human Respiratory Syncytial Virus 100%
• Aerosol 66%
• Diseases 50%
• Death 33%
• Oxygen 16%
• Disease Course 16%
• Placebo-Controlled Study 16%
• Hypoxemia 16%
• Absence 16%